[5/10 - 5/16] Notable Large-Scale Fundraisings

We look back at the top 10 funding rounds announced by U.S. companies this week (May 10–16, 2025). This feature explores the background of large-scale investments across diverse sectors—from AI drug discovery to semiconductor infrastructure, with a focus on healthcare and fintech—and explains each company's future strategy using specific examples and quotes. By delving into round sizes, investor composition, and business development goals, we aim to provide clues for understanding current market trends from multiple perspectives.

1. AI Drug Discovery Pioneer Pathos: $365 Million Large-Scale Funding

New York-based Pathos is a startup that utilizes AI to create precision medicines, including in the oncology field. It raised $365 million in a Series D round, reaching a post-money valuation of approximately $1.6 billion.

• Purpose of Funding: The company stated, "We will strengthen our foundation models and focus specifically on the oncology sector."

• Quote: A Pathos spokesperson commented, "Our AI platform has the potential to shorten the traditional drug discovery process from years to months."

2. Fintech Giant Addepar: $230 Million Funding

Wealth management platform Addepar secured $230 million in a Series G round. The round was led by Vitruvian Partners and WestCap, and clients are currently managing and advising on over $7 trillion in assets through the company's platform.

• Growth Rate: An increase of approximately 40% from $5 trillion a year ago.

• Use of Funds: Strengthening data analysis capabilities and promoting global expansion.

• Quote: The CEO of Addepar stated, "Our vision is to visualize complex asset structures and bring the best decision-making to every investor."

3. Next-Generation Logistics Infrastructure Stord: $200 Million Equity & Debt Funding

Atlanta-based Stord provides end-to-end e-commerce software, fulfillment, and warehousing/transportation services. The company raised a total of $200 million by combining a Series E round with debt financing.

• Lead Investors: Strike Capital (equity), Silicon Valley Bank/Orix USA (debt).

• Goal: "To respond to the surge in demand, we will expand our logistics network and deepen corporate partnerships," said the company's COO.

• Market Background: Since the pandemic, the optimization of last-mile logistics has become a key factor in competitiveness.

4. Personal Finance Stash: $146 Million Series H

Daily investment advice platform Stash raised $146 million in a Series H round. It was led by Goodwater Capital.

• Product: Strengthening "Money Coach AI" to provide expert-level investment strategies to general users in a "real-time" and "personalized" manner.

• Quote: The company's head of product explained, "Our AI aims for a world where people can manage their assets with confidence, even without specialized investment knowledge."

5. Life Insurance Bestow: $120 Million (Equity + Debt)

Dallas-based Bestow has secured $70 million in equity in a Series D round, in addition to $50 million in debt from TriplePoint Capital.

• Business Overview: Providing software for life insurance carriers.

• Investment Background: With the acceleration of DX (digital transformation) in the insurance industry, there is a growing need for highly flexible platforms.

• Quote: A partner at Goldman Sachs Alternatives commented, 'Bestow's technology will dramatically advance the efficiency of everything from insurance underwriting to claims processing.'

6. Restaurant Software Owner: $120 million Series C

Palo Alto-based Owner provides independent restaurants with a unified suite of features including online ordering, mobile apps, loyalty programs, and zero-commission delivery. The round was led by Meritech Capital Partners and Headline.

• Objective: Supporting local small businesses with technology to achieve a customer experience equivalent to that of major chains.

• Quote: The co-founder stated, 'We want to leverage technology to build a restaurant platform that anyone can use immediately.'

7. AI Infrastructure TensorWave: $100 million Series A

Las Vegas-based TensorWave is an AI infrastructure company aiming to deploy one of the world's largest liquid-cooled AMD GPU clusters. Magnetar Capital and AMD Ventures invested $100 million in the Series A round.

• Purpose: 'We are establishing a data center operational structure optimized for modern AI workloads,' said the company's CTO.

• Technology: Adopting a liquid cooling system to implement high-density, high-efficiency GPU clusters.

8. Healthcare SaaS Cohere Health: $90 million Series C

Boston-based Cohere Health develops digital tools for medical authorization and compliance. It raised $90 million in a Series C round led by Temasek.

• Use Case: Automating the insurance coverage determination process using AI and strengthening information-sharing platforms between medical facilities.

• Quote: The company's CEO stated, 'We are simplifying complex medical procedures to reduce the burden on both patients and healthcare providers.'

9. Genetic Medicine Stylus Medicine: $85 million stealth funding

Cambridge (MA)-based Stylus Medicine raised $85 million upon emerging from stealth mode. Investors include Khosla Ventures and RA Capital Management.

• Objective: Accelerating the development of in vivo genetic medicines and therapeutic programs.

• Market Potential: As clinical applications of gene editing technology advance, the biopharmaceutical market is expected to grow at an annual rate of over 20%.

10. Semiconductor Interconnect Avicena Tech: $70 million Series B

Sunnyvale-based Avicena Tech is a developer of ultra-low-power optical interconnects for AI data centers. Tiger Global led the $65 million Series B funding round.

• Use of Funds: Preparing for product commercialization and expanding the team.

• Impact: "Optical interconnects are a key technology for realizing energy savings in next-generation data centers," says the company's CTO.

This concludes our overview of the trends and future developments in each sector through this week's top 10 funding cases. Investment in advanced technology companies, including AI drug discovery and fintech, remains active, and we expect this to continue in the coming weeks.

Related Articles